The rising prevalence of sleep disorders and increasing awareness and health consciousness are expected to boost the growth of the Sleep Testing Market at a CAGR of 11.42% during the forecast period 2025 to 2035

Market Research Future (MRFR) has published a cooked research report on the “Sleep Testing Market” that contains the information from 2019 to 2035.

The Sleep Testing Market is estimated to register a CAGR of 11.42% during the forecast period of 2025 to 2035.

MRFR recognizes the following companies as the key players in the Sleep Testing Market - Koninklijke Philips N.V (Netherlands), ResMed (US), ZOLL Medical Corporation (US), SleepMed Solutions (US), Midwest Sleep Diagnostics Inc. (US), Cadwell Industries Inc. (US), Compumedics Limited (Australia), VirtuOx Inc. (US), Entrusted Medical Devices (India), Wesper (US).

Market Highlights

The Sleep Testing Market is expected to register a CAGR of 11.42% during the forecast period and is estimated to reach USD 95.6 billion by 2035.

The Sleep Testing Market is distinguished by the presence of numerous regional and local players catering to the Sleep Testing Market. Furthermore, the rising prevalence of sleep disorders and increasing awareness and health consciousness are the major factors driving the growth of the Sleep Testing Market. Additionally, it is also projected that growing geriatric population and increasing funding and investment associated with sleep devices and services will boost the market's growth in the upcoming future.

Access full report @ https://www.marketresearchfuture.com/reports/sleep-testing-services-market-7275

Segment Analysis

The Sleep Testing Market has been segmented based on Product & Services, Indication, Age Group, End User.

Based on product & service, the Sleep Testing Market has been segmented into product & service. Product accounted for the largest market share in 2024, and services is projected to grow during the forecast period. Products include Polysomnography Devices, Actigraphy Systems, Oximeters, Respiratory Polygraphs, and Others. Furthermore, Polysomnography Devices further segmented into Clinical Devices, and Ambulatory Devices. And oximeters further bifurcated into Fingertip, Handheld Wrist-worn, and Tabletop. Polysomnography (PSG) devices are essential diagnostic tools in the Sleep Testing Market, offering comprehensive monitoring of various physiological parameters during sleep, such as brain activity, eye movements, muscle tone, heart rate, and respiratory patterns. Actigraphy systems are becoming an increasingly important tool in the sleep testing market, offering a non-invasive, cost-effective, and convenient alternative to traditional sleep studies like polysomnography. The oximeter in sleep testing service market refers to the use of pulse oximeters in the diagnosis and monitoring of sleep disorders, particularly sleep apnea and other conditions that impact oxygen levels during sleep. 

Pulse oximeters measure blood oxygen saturation (SpO2) and pulse rate, which are critical indicators when evaluating sleep health. These devices are integral in-home sleep testing (HST) as well as in clinical sleep labs where sleep-related breathing disorders are diagnosed. Respiratory polygraphs are emerging as a pivotal technology driving the expansion of the Sleep Testing Market, particularly in diagnosing sleep-disordered breathing conditions like obstructive sleep apnea (OSA). Services segmented into In-lab Polysomnography (PSG), Home Sleep Apnea Testing (HSAT), and Sleep Study Consultation Services. In-lab Polysomnography (PSG) is a comprehensive overnight sleep study conducted in specialized sleep centers to diagnose complex sleep disorders such as sleep apnea, narcolepsy, insomnia, and restless leg syndrome. 

Home Sleep Apnea Testing (HSAT) is a convenient and cost-effective diagnostic tool used to identify obstructive sleep apnea (OSA) in patients within the comfort of their own homes. By monitoring key physiological parameters such as airflow, respiratory effort, oxygen saturation, and heart rate, HSAT provides a simplified alternative to traditional in-lab polysomnography (PSG). Sleep study consultation services are a critical component of the Sleep Testing Market, providing expert assessment, diagnosis, and treatment recommendations for patients experiencing sleep disorders.

Based on indication, the Sleep Testing Market has been segmented into sleep apnea, insomnia, narcolepsy, parasomnia, and others. Sleep apnea accounted for the largest market share in 2024, and parasomnia is projected to grow during the forecast period. Sleep apnea is a key driver of growth in the Sleep Testing Market, as its increasing prevalence worldwide has led to higher demand for diagnostic and treatment services. The condition, which causes repeated interruptions in breathing during sleep, is becoming more recognized due to rising awareness, particularly with the aging population and the obesity epidemic. Advances in sleep testing technologies, such as home sleep apnea testing (HSAT) devices and portable monitors, have made diagnosis more accessible and convenient, further expanding market potential. 

Traditional in-lab polysomnography remains the gold standard for sleep apnea diagnosis, but at-home testing is gaining popularity for its ease of use and lower costs. Along with these innovations, increased health insurance coverage, the rise of telemedicine, and the growing recognition of sleep apnea's link to serious health issues like cardiovascular disease and stroke are fueling market growth. As a result, the global demand for sleep testing services is expected to continue rising, particularly in regions like North America and Asia-Pacific, where healthcare systems are increasingly equipped to handle these services.

Based on age group, the Sleep Testing Market has been segmented into children (1 to 17), adult (18 to 60), and geriatric (60 above). Adult accounted for the largest market share in 2024 and children is projected to grow during the forecast period. The adult Sleep Testing Market is experiencing significant growth, driven by an increasing awareness of the link between sleep and overall health, as well as the rising prevalence of sleep disorders. Conditions such as sleep apnea, insomnia, restless legs syndrome, and narcolepsy are becoming more widely recognized, with many adults seeking diagnosis and treatment for their sleep problems. The demand for sleep testing services is particularly strong among individuals experiencing obstructive sleep apnea (OSA), which is often undiagnosed and is associated with serious health risks such as cardiovascular disease, diabetes, and hypertension.

Based on end user, the Sleep Testing Market has been segmented into sleep testing centers, hospitals, home care settings, others. Hospitals accounted for the largest market share in 2024, and home care settings is projected to grow during the forecast period. Hospitals play a critical role in the Sleep Testing Market, offering specialized diagnostic facilities for patients with sleep disorders. Many hospitals are equipped with advanced polysomnography (PSG) labs and other diagnostic tools to conduct comprehensive sleep studies, especially for severe or complex conditions like sleep apnea, narcolepsy, and parasomnias. Hospitals provide an ideal setting for patients who require close monitoring and immediate medical intervention during their sleep studies, ensuring a higher level of care and accuracy in diagnoses. In addition to traditional in-lab testing, hospitals increasingly integrate home sleep testing (HST) and telemedicine solutions to expand access to sleep diagnostics, making it easier for patients to undergo studies without the need for overnight stays. With rising awareness of the importance of sleep health, hospitals are also focusing on multidisciplinary care, combining sleep medicine with other specialties like cardiology, pulmonology, and neurology to offer more comprehensive treatment plans.

Regional Analysis

Based on the region, the Sleep Testing Market has been segmented into north America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America accounted for the largest market share in 2024.

The sleep testing market in North America is experiencing significant growth, driven by the rising prevalence of sleep disorders like sleep apnea, insomnia, and narcolepsy, as well as increased awareness about the importance of sleep health. For instance, according to the American Sleep Apnea Association, it is estimated that 22 million Americans suffer from sleep apnea, with 80% of moderate and severe cases undiagnosed. This provides a significant opportunity for sleep testing to grow. With obstructive sleep apnea affecting millions of people, the demand for diagnostic services, such as home sleep apnea tests (HSATs) and in-lab polysomnography (PSG), is on the rise. Technological advancements, including wearable devices and telemedicine, are also playing a crucial role in expanding access to sleep testing. Moreover, an aging population and increasing rates of chronic conditions such as obesity and hypertension are contributing to the growing need for sleep disorder diagnoses. North America's healthcare system, along with government initiatives and insurance reimbursements, further supports market growth by making sleep testing more accessible.

Furthermore, the sleep testing market in Europe is witnessing significant growth, fueled by an increasing awareness of sleep disorders such as sleep apnea, insomnia, and restless leg syndrome, as well as the rising prevalence of conditions linked to poor sleep, including obesity and cardiovascular diseases. For instance, The European Sleep Apnea Group (ESAG) estimates that sleep apnea affects approximately 4% of men and 2% of women in Europe, but only a fraction of those individuals are diagnosed and treated. Moreover, with over 100 million people affected by sleep apnea in Europe, of which an estimated 80% remain undiagnosed, the demand for both in-lab polysomnography (PSG) and home sleep apnea testing (HSAT) is rapidly rising. Advancements in diagnostic technology, such as home sleep apnea testing (HSAT) and telemedicine, are enhancing accessibility and convenience, enabling patients to seek testing services remotely or at home. This trend is especially prevalent in countries with strong healthcare infrastructures like Germany, France, and the UK, where both in-lab polysomnography (PSG) and home testing are widely available.

Also, the sleep testing market in the Asia-Pacific (APAC) region is expanding rapidly, driven by a combination of rising awareness of sleep disorders, an aging population, and increasing healthcare access. Sleep disorders, particularly sleep apnea, insomnia, and narcolepsy, are becoming more prevalent across APAC due to lifestyle changes, urbanization, and growing levels of stress. The region's diverse population, ranging from highly developed economies like Japan, South Korea, and Australia, to emerging markets in China, India, and Southeast Asia, presents both opportunities and challenges for sleep testing service providers.

The sleep testing market in South America is gradually expanding, fueled by increasing awareness of sleep disorders such as sleep apnea, insomnia, and restless leg syndrome. As the region faces rising obesity rates, urbanization, and stress-related health issues, the demand for sleep diagnostics is growing, particularly in countries like Brazil, Argentina, and Chile. The adoption of home sleep apnea testing (HSAT) is becoming more popular due to its affordability and convenience, while advancements in wearable devices and mobile health apps are further driving interest in sleep disorder diagnosis. The region’s aging population, particularly in countries like Brazil, is also contributing to the demand for sleep testing, as older adults are more likely to suffer from sleep conditions.

The Middle East & Africa is further segmented into GCC Countries, South Africa, and Rest of Middle East & Africa. Sleep apnea, particularly obstructive sleep apnea (OSA), is one of the primary conditions driving demand for sleep testing in the MEA region. In countries like Saudi Arabia, UAE, and Egypt, obesity, smoking, and air pollution contribute to the rising incidence of sleep apnea. For instance, the UAE has one of the highest obesity rates globally, with 27% of the adult population classified as obese. Saudi Arabia reports 35% of the population being obese, which further fuels the demand for sleep testing. A significant percentage of the population remains undiagnosed, creating a major market opportunity for diagnostic services. Insomnia is also on the rise due to urbanization, increasing levels of stress, and lifestyle changes. As more people face sleep disturbances, the demand for accurate diagnoses and treatment solutions is growing. UAE and Qatar also report higher-than-average insomnia rates, driven by urban stress and changing lifestyles.

Key Findings of the Study

• The Sleep Testing Market is expected to reach USD 95.6 billion by 2035, at a CAGR of 11.42% during the forecast period.


• The North America sleep testing market accounted largest share in 2024


• Based on Product & Services, Product segment held the majority share in 2024.


• Koninklijke Philips N.V (Netherlands), ResMed (US), ZOLL Medical Corporation (US), SleepMed Solutions (US), Midwest Sleep Diagnostics Inc. (US), Cadwell Industries Inc. (US), Compumedics Limited (Australia), VirtuOx Inc. (US), Entrusted Medical Devices (India), Wesper (US) are the key market players.